Dysregulated protocadherin-pathway activity as an intrinsic defect in induced pluripotent stem cell-derived cortical interneurons from subjects with schizophrenia
- PMID: 30664768
- PMCID: PMC6373728
- DOI: 10.1038/s41593-018-0313-z
Dysregulated protocadherin-pathway activity as an intrinsic defect in induced pluripotent stem cell-derived cortical interneurons from subjects with schizophrenia
Abstract
We generated cortical interneurons (cINs) from induced pluripotent stem cells derived from 14 healthy controls and 14 subjects with schizophrenia. Both healthy control cINs and schizophrenia cINs were authentic, fired spontaneously, received functional excitatory inputs from host neurons, and induced GABA-mediated inhibition in host neurons in vivo. However, schizophrenia cINs had dysregulated expression of protocadherin genes, which lie within documented schizophrenia loci. Mice lacking protocadherin-α showed defective arborization and synaptic density of prefrontal cortex cINs and behavioral abnormalities. Schizophrenia cINs similarly showed defects in synaptic density and arborization that were reversed by inhibitors of protein kinase C, a downstream kinase in the protocadherin pathway. These findings reveal an intrinsic abnormality in schizophrenia cINs in the absence of any circuit-driven pathology. They also demonstrate the utility of homogenous and functional populations of a relevant neuronal subtype for probing pathogenesis mechanisms during development.
Conflict of interest statement
Conflict of interest
Thomas Lanz and Hualin Simon Xi were employees of Pfizer, Inc at the time this work was performed.
Figures
References
-
- Sullivan PF, Kendler KS & Neale MC Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Archives of general psychiatry 60, 1187–1192 (2003). - PubMed
-
- Weinberger DR Implications of normal brain development for the pathogenesis of schizophrenia. Archives of general psychiatry 44, 660–669 (1987). - PubMed
-
- Buchanan RW & Carpenter WT Domains of psychopathology: an approach to the reduction of heterogeneity in schizophrenia. The Journal of nervous and mental disease 182, 193–204 (1994). - PubMed
-
- Elvevag B & Goldberg TE Cognitive impairment in schizophrenia is the core of the disorder. Critical reviews in neurobiology 14, 1–21 (2000). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
